BLOG

OGC Perspectives

Legal insights that drive strategy — not just compliance.

Latest Posts

General counsel GC billable hour frustration
Addressing the Frustrations of General Counsel: the OGC Solution 1360 770 Lynn Kuzneski

Addressing the Frustrations of General Counsel: the OGC Solution

HIPAA Final Rule reproductive health care privacy
New HIPAA Rule Enhances Privacy Protections for Reproductive Health Information 1254 836 Lynn Kuzneski

New HIPAA Rule Enhances Privacy Protections for Reproductive Health Information

OGC Mergers and Acquisitions
ZoomRx and OGC: An M&A Success Story 1365 768 Lynn Kuzneski

ZoomRx and OGC: An M&A Success Story

OGC Elizabeth Smith life sciences attorney
Meet the OGCs: Elizabeth Smith 1024 546 Lynn Kuzneski

Meet the OGCs: Elizabeth Smith

James Jamie Duberman OGC
Meet the OGCs: James Duberman 1024 546 Lynn Kuzneski

Meet the OGCs: James Duberman

OGC Anita Drummond
Meet the OGCs: Anita Drummond 1024 546 Lynn Kuzneski

Meet the OGCs: Anita Drummond

legal advice
Empowering Business Growth: The Impact of An In-House Lawyering Approach 1373 764 Lynn Kuzneski

Empowering Business Growth: The Impact of An In-House Lawyering Approach

Legal advice
Big Law Profits Soar Compounding the In-House Budget Squeeze 1217 861 Lynn Kuzneski

Big Law Profits Soar Compounding the In-House Budget Squeeze

Venture finance transactions and Moelis decision
Moelis Decision Impact on Venture-Backed Companies: Considerations for Venture Financing 1289 813 Lynn Kuzneski

Moelis Decision Impact on Venture-Backed Companies: Considerations for Venture Financing

OGC partner Stacey Heller
Meet the OGCs: Stacey Heller 1024 546 Lynn Kuzneski

Meet the OGCs: Stacey Heller

Texas Court Enjoins Enforcement of FTC’s Non-Compete Ban Nationwide
Federal Trade Commission Bans Non-Competes for Virtually All Workers Nationwide 974 514 Lynn Kuzneski

Federal Trade Commission Bans Non-Competes for Virtually All Workers Nationwide

BIOSECURE Act life sciences biotech pharma
Understanding the Proposed BIOSECURE Act and What it Means for U.S. Life Sciences Companies 1254 836 Lynn Kuzneski

Understanding the Proposed BIOSECURE Act and What it Means for U.S. Life Sciences Companies

YOUR PARTNER

Outside GC.
Inside Advantage.

Business-minded counsel, delivered with an in-house perspective.

Outside GC Logo
501 Boylston Street,
10th Floor Boston, MA 02116

Stay In The Know

Quicklinks